SCHEMBL3752578

SCHEMBL3752578

COc1ccc2c(Oc3ccc4ccccc4c3C(=O)NCc3ccc(C(=O)Nc4ccccc4N)cn3)ccnc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 1/20 0.57
HDAC1 Q13547 11/20 0.47
KDR P35968 5/20 0.42
MET P08581 4/20 0.42
AURKA O14965 2/20 0.42
TEK Q02763 2/20 0.42
HDAC3 O15379 3/20 0.42
HDAC2 Q92769 3/20 0.42
HDAC10 Q969S8 3/20 0.42
HDAC4 P56524 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC9 Q9UKV0 2/20 0.42
HDAC5 Q9UQL6 2/20 0.42
NCOR2 Q9Y618 1/20 0.42
ADORA2A P29274 1/20 0.41
IGF1R P08069 2/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3758006 0.91 HDAC1 (0.46) PDGFRAHDAC1KDRMETHDAC2
SCHEMBL7788968 0.86 PDGFRA (0.76) PDGFRAKDRMETAURKATEK
SCHEMBL3750220 0.83 KDR (0.47) HDAC1KDRMETAURKATEK
SCHEMBL7784223 0.80 PDGFRA (0.66) PDGFRAKDRMETAURKATEK
SCHEMBL3753804 0.78 PDGFRA (0.80) PDGFRAHDAC1KDRMETAURKA
SCHEMBL3758003 0.76 MET (0.47) PDGFRAKDRMETHDAC3HDAC2
Ibcasertib SCHEMBL3757428 0.73 PDGFRA (1.00) PDGFRAKDRMETAURKATEK
Ibcasertib SCHEMBL29369945 0.73 PDGFRA (1.00) PDGFRAKDRMETAURKATEK
Ibcasertib SCHEMBL29883432 0.73 PDGFRA (1.00) PDGFRAKDRMETAURKATEK
SCHEMBL7783999 0.72 KDR (0.62) PDGFRAKDRMETAURKATEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8211901-B2 Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2012-07-03 US disclosed
US-20100298358-A1 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298358-A1 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors HDAC1, HDAC2, HDAC5 PDGFRA 1852/4885HDAC1 1/4885KDR 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.